SB 203580

SB 203580

Catalog Number:
L002369446APE
Mfr. No.:
APE-A8254
Price:
$188
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          SB203580, also called 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl) 1Himidazole [6], is a specific pyridinyl imidazole inhibitor of p38-MAPK (Mitogen-activated Protein Kinase) signaling pathway [1] [3]. It was competitive with ATP with a selectivity probably determined by nonconserved regions within or near the ATP binding pocket and a Ki of 21 nM [3]. It inhibits c-Raf with an IC50 of 2 mM in vitro [4].p38 MAPK signaling pathway enables cells to generate a plethora of different effects to interpret a wide range of external signals and respond appropriately. There is a core of three protein kinases acting sequentially in this pathway to ensure the diversity and specificity in cellular outcomes [5].Exposure to 30 mM SB203580 significantly decreased the resistance of L1210/VCR cells to vincristine accompanied by the LC50 value of vincristine changed from 3.2036±0.521 to 0.5576±0.082 mM. Exposure to 10 mM SB203580 slightly changed the value of the resistance index, accompanied by the LC50 values of SB203580 to sensitive L1210 cells and to resistant cells were 39.26±2.2 mM and 52.06±7.6 mM, respectively [1].In vivo, administration of SB203580 alone 24 h before the permanent middle cerebral arterial occlusion abolished the isoflurane preconditioning-induced neuroprotection. After isoflurane exposure, administration of SB203580 decreased phosphorylated p38 MAPK. SB203580 inhibited anisomycin pretreatment-induced neuroprotection [6].

          [1]. Miroslav Baranclk, Vierka Bohacova, Janka Kvackajova, et al. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. European Journal of Pharmaceutical Sciences, 2001, 14: 29-36.
          [2]. Shuqiu Zheng and Zhiyi Zuo. Isoflurane Preconditioning Induces Neuroprotection against Ischemia via Activation of P38 Mitogen-Activated Protein Kinases. Molecular Pharmacology, 2004, 65:1172-1180.
          [3]. Peter R. Young, Megan M. McLaughlin, Sanjay Kumar, et al. Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Site. The Journal of Biological Chemistry, 1997, 272(18): 12116-12121.
          [4]. Clare A Hall-Jackson, Michel Goedert, Philip Hedge, et al. E€ect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene, 1999, 18: 2047-2054.
          [5]. Ana Cuadrado and Angel R. Nebreda. Mechanisms and functions of p38 MAPK signalling. Biochem. J., 2010, 429: 403-417.
          [6]. Shuqiu Zheng and Zhiyi Zuo. Isoflurane Preconditioning Induces Neuroprotection against Ischemia via Activation of P38 Mitogen-Activated Protein Kinases. Mol Pharmacol, 2004, 65: 1172-1180.

      • Properties
        • Alternative Name
          4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
          CAS Number
          152121-47-6
          Molecular Formula
          C21H16FN3OS
          Molecular Weight
          377.44
          Purity
          98.00%
          Solubility
          insoluble in H2O; ≥18.872 mg/mL in DMSO; ≥3.28 mg/mL in EtOH with ultrasonic
          Storage
          Desiccate at 4°C

          * For Research Use Only

      • Reference
        • 1. Yuhan Wang, Li Zhao, et al. "Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment." Bioengineered. 2022 Mar;13(3):5880-5891. PMID: 35184673
          2. Jingman Li, Yuchen Pan, et al. "Urokinase-type plasminogen activator receptor is required for impairing toll-like receptor 7 signaling on macrophage efferocytosis in lupus." Mol Immunol. 2020 Nov;127:38-45. PMID: 32911323
          3. Ruibin Bai, Yajie Zhang, et al. "Isolation, characterization and immunomodulatory activity of oligosaccharides from Codonopsis pilosula." Journal of Functional Foods. Volume 72, September 2020, 104070
          4. Yang L, Wu D, et al. "Upregulation of microRNA-195 ameliorates calcific aortic valve disease by inhibiting VWF via suppression of the p38-MAPK signaling pathway." Int J Cardiol. 2020 Jun 15;309:101-107. PMID: 32188582
          5. Liu B, Shen LJ, et al. "Automobile exhaust-derived PM(2.5) induces blood-testis barrier damage through ROS-MAPK-Nrf2 pathway in sertoli cells of rats." Ecotoxicol Environ Saf. 2020 Feb;189:110053. PMID: 31862514
          6. Xianglan Wei, Siyao Li, et al. "Pomegranate peel extract ameliorates liver fibrosis induced by carbon tetrachloride in rats through suppressing p38MAPK/Nrf2 pathway." Journal of Functional Foods, https://doi.org/10.1016/j.jff.2019.103712.
          7. Bhattacharya U, Gutter-Kapon L, et al. "Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth." Cancer Res. 2020 Jan 1;80(1):57-68. PMID: 31690669
          8. Ha SD, Cho W, et al. "The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1β eRNA and mRNA transcription in mouse melanoma and macrophage cell lines." J Biol Chem. 2019 Nov 15;294(46):17487-17500. PMID: 31586032
          9. Hazzan T, Eberle J, et al. "Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT5/Mcl-1 and JNK/Bcl-x(L)." Cells. 2019 Aug 5;8(8). pii: E829. PMID: 31387206
          10. Zhao J, Cao J, et al. "Dehydroepiandrosterone alleviates E. Coli O157:H7-induced inflammation by preventing the activation of p38 MAPK and NF-κB pathways in mice peritoneal macrophages." Mol Immunol. 2019 Oct;114:114-122. PMID: 31351412
          11. Liu W, Zhan C, et al. "Microcystin-LR influences the in vitro oocyte maturation of zebrafish by activating the MAPK pathway." Aquat Toxicol. 2019 Oct;215:105261. PMID: 31419757
          12. Wang Z, Guhl S, et al. "IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming." Cells. 2019 Apr 11;8(4). pii: E341. PMID: 30979016
          13. Wang Q, Zhou C, et al. "The involvement of the ERK-MAPK pathway in TGF-β1-mediated connexin43-gap junction formation in chondrocytes. Connect Tissue Res." 2019 Mar 22:1-10. PMID: 30897973
          14. Vincent Picher-Martel. "L’implication de l’ubiquiline-2 dans l’agrégation de TDP-43 et la pathogénèse de la sclérose latérale amyotrophique." University Laval. 2019.
          15.Jin X, Ding D, et al. "Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression." Mol Cell. 2019 Jan 3;73(1):22-35.e6. PMID: 30527665
          16. Grun D, Adhikary G, et al. "NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival." Mol Carcinog. 2018 Nov 19. PMID: 30456845
          17. He GR, Lin XK, et al. "Dexmedetomidine impairs P glycoprotein mediated efflux function in L02 cells via the adenosine 5' monophosphate activated protein kinase/nuclear factor κB pathway." Mol Med Rep.2018 Apr;17(4):5049-5056. PMID: 29393492
          18. Yang M, Wang L, et al. "Helicobacter pylori cytotoxin-associated gene A impairs the filtration barrier function of podocytes via p38 MAPK signaling pathway." Acta Biochim Pol. 2017;64(3):471-475. PMID: 28803254
          19. Duggan BM, Foley KP, et al."Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia." Sci Rep. 2017 May 8;7(1):1578. PMID: 28484277
          20. Cui Y, Sun Y, et al. "Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals." Oncogene. 2016 Jul 4. PMID: 27375022

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.